pillbase.ru

Crysvita

Active substance: Burosumab

burosumab

Centralised EU authorisationActive

Marketing holder: Kyowa Kirin Holdings B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • CRYSVITA
    INJECTION · BUROSUMAB 30 mg/mL
    42747-304
    Kyowa Kirin, Inc.
  • CRYSVITA
    INJECTION · BUROSUMAB 10 mg/mL
    42747-102
    Kyowa Kirin, Inc.
  • CRYSVITA
    INJECTION · BUROSUMAB 20 mg/mL
    42747-203
    Kyowa Kirin, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-9016-71f3-bae7-7a9309056702,01a12095-c12f-776a-8bce-be56ca9efb83,01a12098-679f-725f-8113-add72c903861;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004275
Registration status
Active
ATC code
M05BX05
Sources
  • product · EMA · EMEA/H/C/004275 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004275 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004275 · Verified 2026-10-09